Use of Novel Peptide, ATAP, for Inducing Cancer Cell Death May be More Successful than Current Peptide-Based Therapies
Thursday, January 20, 2011 - 17:00
in Health & Medicine
Researchers from UMDNJ-Robert Wood Johnson Medical School have discovered a novel peptide that can act as a potent inducer of cancer cell death, which may have significant implications for therapeutic agents used to treat cancer. Their study indicates that the amphipathic tail-anchoring peptide, or ATAP, may provide more successful outcomes in cancer treatment than the BH3 peptide-based therapy currently used. The study was released online December 28, 2010, as a Paper of the Week in the Journal of Biological Chemistry.